JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation

Gilyoung Lee, Huijeong Ahn, Jang Hyuk Yun, Jeongho Park, Eunsong Lee, Seikwan Oh, Geun Shik Lee

Research output: Contribution to journalArticlepeer-review


Dysregulation of inflammasome activation induces chronic and excess inflammation resulting in several disorders, such as metabolic disorders and cancers. Thus, screening for its regulator derived from natural materials has been conducted progressively. JC2-11 (JC) was designed to enhance the antioxidant activity based on a chalcone, which is abundant in edible plants and a precursor of flavonoids. This study examined the effects of JC on inflammasome activation in human and murine macrophages. JC inhibited the secretion of interleukin (IL)-1β and lactate dehydrogenases, and the cleavage of caspase-1 and gasdermin D in response to the tested activators (i.e., NLRP3, NLRC4, AIM2, and non-canonical inflammasome triggers). In addition, JC attenuated IL-1β secretion from lipopolysaccharide (LPS)-injected mice, an inflammasome-mediating disease model. Mechanistically, JC blocked the expression of the inflammasome components during the priming step of the inflammasome, and interrupted the production of mitochondrial reactive oxygen species. In addition, JC inhibited the activity of caspase-1. In conclusion, JC may be a candidate pan-inflammasome inhibitor.

Original languageEnglish
Article number22484
JournalScientific Reports
Issue number1
StatePublished - Dec 2022


Dive into the research topics of 'JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation'. Together they form a unique fingerprint.

Cite this